Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1/2 Trial of ALM-488 in Patients Undergoing Head & Neck Surgery

NCT04420689 is registered in ClinicalTrials.gov with Alume Biosciences, Inc. as lead sponsor.

NCT NCT04420689
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04420689 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1/2 Trial of ALM-488 in Patients Undergoing Head & Neck Surgery
Lead sponsor
Alume Biosciences, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
June 18, 2020
Completion date
February 15, 2022
Enrollment
27 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck neoplasms, imaging, nerve injury, parotid neoplasm, surgery, thyroid neoplasms